Clinical Trials Directory

Trials / Completed

CompletedNCT00128024

Effects of Early Statin Treatment After Acute Myocardial Infarction (AMI) in Japanese Patients

Effects of Early Statin Treatment on Symptomatic Heart Failure and Ischemic Events After Acute Myocardial Infarction. The MUSASHI-AMI: A Multicenter Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
460 (actual)
Sponsor
Kumamoto University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Statins have been shown to prevent coronary artery disease and to preserve left ventricular function in dilated cardiomyopathy. The investigators hypothesized that the early use of statins would reduce cardiovascular events including heart failure in acute myocardial infarction patients. The purpose of this study is to determine whether early (within 96 hours after onset) use of any available statins are effective to prevent cardiovascular events including heart failure after acute myocardial infarction in Japanese patients.

Detailed description

At least, in Japanese, it was controversial if lipid-lowering therapy to the patients whose total cholesterol levels \<240 mg/dL was needed. Furthermore, in general, a role for early statin therapy in patients with ST-elevated AMI reperfused by primary PCI has not been clearly established. Statins have been shown to prevent coronary artery disease and to preserve left ventricular function in dilated cardiomyopathy. The investigators hypothesized that the early use of statins would reduce cardiovascular events including heart failure in acute myocardial infarction patients. A prospective, randomized, open-label, multicenter trial is conducted in AMI patients with normal total cholesterol levels (180-240 mg/dL). Patients are randomly assigned to receive any available statin within 96 hours of AMI onset or no statin and were followed for up to 24 months. The primary endpoint is a composite of cardiovascular death, nonfatal AMI, recurrent symptomatic myocardial ischemia, congestive heart failure, and stroke.

Conditions

Interventions

TypeNameDescription
DRUGlipid-lowering treatment

Timeline

Start date
2002-02-01
Primary completion
2004-02-01
Completion
2006-02-01
First posted
2005-08-09
Last updated
2013-04-18

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00128024. Inclusion in this directory is not an endorsement.